170 related articles for article (PubMed ID: 1862751)
1. Comparative study of in vitro inhibition of activation of the classical and alternative pathways of human complement by the magnesium and sodium salts of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA).
Feuillard J; Maillet F; Goldschmidt P; Weiss L; Kazatchkine MD
Agents Actions; 1991 Mar; 32(3-4):343-6. PubMed ID: 1862751
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
Etievant M; Leluc B; David B
Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498
[TBL] [Abstract][Full Text] [Related]
3. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Sharma S
J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
Peake PW; Pussell BA; Martyn P; Timmermans V; Charlesworth JA
Int J Immunopharmacol; 1991; 13(7):853-7. PubMed ID: 1761351
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
Asghar SS; de Koster A; van der Helm HJ
Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase.
Strunk RC; Webster RO
Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899
[TBL] [Abstract][Full Text] [Related]
7. [A peptide (a magnesium salt of N-acetyl (alpha, beta)-aspartyl-glutamic acid). Demonstration of the protection against local cellular destruction induced by in situ complement activation].
Chevance LG; Etiévant M
J Pharmacol; 1986; 17(4):676-85. PubMed ID: 3560976
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of factor J on the alternative complement pathway.
González-Rubio C; Jiménez-Clavero MA; Fontán G; López-Trascasa M
J Biol Chem; 1994 Oct; 269(42):26017-24. PubMed ID: 7929312
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
[TBL] [Abstract][Full Text] [Related]
11. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
Weiler JM; Gleich GJ
J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the classical and alternative pathways of the human complement system by glycosaminoglycan polysulfate.
de Messias IT; Mohren D; Kajdacsy-Balla A
J Investig Allergol Clin Immunol; 1994; 4(4):172-6. PubMed ID: 7850029
[TBL] [Abstract][Full Text] [Related]
14. The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes.
Leslie RG; Nielsen CH
Immunology; 2004 Jan; 111(1):86-90. PubMed ID: 14678202
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
16. Regulation of C5 convertase activity by properdin, factors B and H.
Weiler JM
Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
[No Abstract] [Full Text] [Related]
17. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of complement by gold sodium thiomalate.
Hasselbacher P
J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
[TBL] [Abstract][Full Text] [Related]
19. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
20. Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D.
González-Rubio C; González-Muñiz R; Jiménez-Clavero MA; Fontán G; López-Trascasa M
Biochim Biophys Acta; 1996 Jul; 1295(2):174-8. PubMed ID: 8695643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
